The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants
2020 · Nature Communications · 115 citations
https://doi.org/10.1038/s41467-020-14829-5
M
Mark Layton
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
117
Papers
3.0K
Citations
31
h-index
59
i10-index
Mark Layton is an academic researcher from Imperial College Healthcare NHS Trust. The author has contributed to research in topics: Hemoglobinopathies and Related Disorders & Erythrocyte Function and Pathophysiology & Neonatal Health and Biochemistry. The author has an h-index of 31, co-authored 100 publications.
ORCID: 0000-0002-1219-1321Papers by this author
worksTelomerecat: A ploidy-agnostic method for estimating telomere length from whole genome sequencing data
2018 · Scientific Reports · 90 citations
https://doi.org/10.1038/s41598-017-14403-y
Laboratory diagnosis of G6PD deficiency. A British Society for Haematology Guideline
2020 · British Journal of Haematology · 53 citations
https://doi.org/10.1111/bjh.16366
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat